Plain language summary
The MYMOP (Measure Yourself Medical Outcome Profile) questionnaire allows patients to select up to two symptoms that concern them most, and to subjectively assess the change of these symptoms over time following a therapeutic intervention. The aim of this study was to translate the MYMOP2 questionnaire into Turkish and add this questionnaire into Turkish medical practice and culture and assess its validity and reliability among the patients with anorectal disorders - medical disorders that occur at the junction of the anal canal and the rectum - (chronic constipation, anal incontinence, chronic pelvic pain). The MYMOP2 consists of four questions. All questions have to be rated on 7-point Likert-type scales. The study included fifty-seven patients who presented anorectal disorders. The MYMOP2 was compared to the NHP (Nottingham Health Profile) to test its construct validity. Results indicate that the Turkish version of the MYMOP2 proved to be both valid and reliable. Authors conclude that since the Turkish version of MYMOP2 is short and simple to fill-in, it can be easily incorporated into many health care, as well as gastroenterology, settings. It might be an important tool to enhance patient-centred care.
Abstract
BACKGROUND/AIMS: Measure Yourself Medical Outcome Profile 2 (MYMOP2) is a patient-generated outcome measure allowing patients to select the problems that are the most important to them and that they want to address, and it measures the effects of the problem from a wide range of health care interventions. This study aimed to translate the questionnaire into Turkish language (Turkish MYMOP-TMYMOP) and add this clinically useful measure to Turkish medical practice by assessing its validity and reliability. MATERIALS AND METHODS Fifty volunteers with anorectal disorders were prospectively included into the study. Each patient was enrolled into a pelvic floor training biofeedback program, specific to their anorectal symptomatology. The subjects were administered both the Nottingham Health Profile and the TMYMOP2 questionnaires before the treatment session (initial visit) and at the control follow-up visits (the first and second months, via e-mail or telephone calls). RESULTS The TMYMOP2 questionnaire was shown to be moderately valid (the Pearson correlation coefficient score between the total scores of the subgroups of the two questionnaires were 0.335 and 0.642, respectively, p<0.05) and highly reliable (the Cronbach's alfa coefficient score between the total scores of the subgroups of the two questionnaires were 0.77, 0.82, and 0.88 in the beginning and at the first and second month follow-up visits, respectively). CONCLUSION The TMYMOP2 was shown to be a low-to-moderately valid and a highly reliable scale. Because it is brief and short to complete, it might be an important and free-to-use tool to measure the diseases, and it can enhance the patient-centered care within the Turkish health care context.
Methodological quality
Allocation concealment
:
Not applicable
